Cargando…

Functional Dependency Analysis Identifies Potential Druggable Targets in Acute Myeloid Leukemia

SIMPLE SUMMARY: New drugs are needed for treating acute myeloid leukemia (AML). We analyzed data from genome-edited leukemia cells to identify druggable targets. These targets were necessary for AML cell survival and had favorable binding sites for drug development. Two lists of genes are provided f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yujia, Takacs, Gregory P., Lamba, Jatinder K., Vulpe, Christopher, Cogle, Christopher R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764352/ https://www.ncbi.nlm.nih.gov/pubmed/33321907 http://dx.doi.org/10.3390/cancers12123710

Ejemplares similares

NF-κB: A Druggable Target in Acute Myeloid Leukemia
por: Di Francesco, Barbara, et al.
Publicado: (2022)

Proteomics: a new era in pediatric acute myeloid leukemia research
por: Lamba, Jatinder K., et al.
Publicado: (2022)

Angiogenesis in Acute Myeloid Leukemia and Opportunities for Novel Therapies
por: Trujillo, Angelica, et al.
Publicado: (2012)

Discovery of druggable cancer-specific pathways with application in acute myeloid leukemia
por: Trac, Quang Thinh, et al.
Publicado: (2022)

Current Landscape of Genome-Wide Association Studies in Acute Myeloid Leukemia: A Review
por: Marrero, Richard J., et al.
Publicado: (2023)

Targeted Therapies and Druggable Genetic Anomalies in Acute Myeloid Leukemia: From Diagnostic Tools to Therapeutic Interventions
por: Lanza, Francesco, et al.
Publicado: (2021)

Integrated epigenetic and genetic analysis identifies markers of prognostic significance in pediatric acute myeloid leukemia
por: Lamba, Jatinder K., et al.
Publicado: (2018)

Endothelial cell derived angiocrine support of acute myeloid leukemia targeted by receptor tyrosine kinase inhibition
por: Drusbosky, Leylah, et al.
Publicado: (2015)

MicroRNAs Mediated Regulation of Expression of Nucleoside Analog Pathway Genes in Acute Myeloid Leukemia
por: Bhise, Neha S., et al.
Publicado: (2019)

Correction: Integrated epigenetic and genetic analysis identifies markers of prognostic significance in pediatric acute myeloid leukemia
por: Lamba, Jatinder K., et al.
Publicado: (2018)

Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemia
por: Rocca, Stefania, et al.
Publicado: (2018)

Druggable Biochemical Pathways and Potential Therapeutic Alternatives to Target Leukemic Stem Cells and Eliminate the Residual Disease in Chronic Myeloid Leukemia
por: Muselli, Fabien, et al.
Publicado: (2019)

Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
por: Stockard, Bradley, et al.
Publicado: (2018)

A 6-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia
por: Elsayed, Abdelrahman H., et al.
Publicado: (2019)

Potential targeting of FLT3 acute myeloid leukemia
por: Ambinder, Alexander J., et al.
Publicado: (2020)

Lysosomes in acute myeloid leukemia: potential therapeutic targets?
por: Rafiq, Sreoshee, et al.
Publicado: (2021)

Building a precision oncology workforce by multidisciplinary and case-based learning
por: Chamala, Srikar, et al.
Publicado: (2021)

Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AML
por: Nguyen, Nam H. K., et al.
Publicado: (2022)

Systematic molecular profiling of acute leukemia cancer stem cells allows identification of druggable targets
por: Salavaty, Adrian, et al.
Publicado: (2022)

Functional Integration of Acute Myeloid Leukemia into the Vascular Niche
por: Cogle, Christopher R., et al.
Publicado: (2014)

Expression and functional characterization of CD33 transcript variants in human acute myeloid leukemia
por: Laszlo, George S., et al.
Publicado: (2016)

The potential role of the thymus in immunotherapies for acute myeloid leukemia
por: Hino, Christopher, et al.
Publicado: (2023)

Integrated genomic analysis to identify druggable targets for pancreatic cancer
por: Mugiyanto, Eko, et al.
Publicado: (2022)

Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma
por: Chow, Yock Ping, et al.
Publicado: (2017)

Kinases as Druggable Targets in Trypanosomatid Protozoan Parasites
por: Merritt, Christopher, et al.
Publicado: (2014)

Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemia
por: Dillon, Laura W., et al.
Publicado: (2019)

Using RNA-seq and targeted nucleases to identify mechanisms of drug resistance in acute myeloid leukemia
por: Rathe, Susan K., et al.
Publicado: (2014)

Druggable Molecular Pathways in Chronic Lymphocytic Leukemia
por: Almasri, Mohammad, et al.
Publicado: (2022)

Targeting chemoresistance and mitochondria-dependent metabolic reprogramming in acute myeloid leukemia
por: Feng, Lili, et al.
Publicado: (2023)

Targeting MTHFD2 in acute myeloid leukemia
por: Pikman, Yana, et al.
Publicado: (2016)

Targets for chimeric antigen receptor T-cell therapy of acute myeloid leukemia
por: Schorr, Christopher, et al.
Publicado: (2022)

Molecular targeting in acute myeloid leukemia
por: Lim, Seah H., et al.
Publicado: (2017)

Identifying Druggable Targets by Protein Microenvironments Matching: Application to Transcription Factors
por: Liu, T, et al.
Publicado: (2014)

DNA Methylation‐Based Epigenetic Repression of SLC22A4 Promotes Resistance to Cytarabine in Acute Myeloid Leukemia
por: Buelow, Daelynn R., et al.
Publicado: (2020)

Analysis of Cancer Genomic Amplifications Identifies Druggable Collateral Dependencies within the Amplicon
por: Pons, Guillem, et al.
Publicado: (2023)

Reductive carboxylation of glutamine as a potential target in acute myeloid leukemia
por: Roma, Alessia, et al.
Publicado: (2023)

Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic Indicators
por: Fornerod, Maarten, et al.
Publicado: (2021)

FUS-dependent microRNA deregulations identify TRIB2 as a druggable target for ALS motor neurons
por: Ho, Wan Yun, et al.
Publicado: (2023)

Technical Advances in the Measurement of Residual Disease in Acute Myeloid Leukemia
por: Roloff, Gregory W., et al.
Publicado: (2017)

Targeted Therapies for the Evolving Molecular Landscape of Acute Myeloid Leukemia
por: Ahmadmehrabi, Khashayar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pqbekfc9ascisq4vm4g8bfljtl